News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
105,263 Results
Type
Article (15912)
Company Profile (25)
Press Release (89326)
Section
Business (31296)
Career Advice (996)
Deals (5807)
Drug Delivery (71)
Drug Development (13361)
Employer Resources (145)
FDA (2683)
Job Trends (3790)
News (52851)
Policy (5109)
Tag
Academia (668)
Alliances (8030)
Alzheimer's disease (341)
Antibody-drug conjugate (ADC) (48)
Approvals (2657)
Artificial intelligence (70)
Bankruptcy (60)
Best Places to Work (2052)
Cancer (303)
Career advice (850)
CAR-T (33)
Cell therapy (83)
Clinical research (10148)
Collaboration (95)
COVID-19 (769)
C-suite (30)
Data (269)
Denatured (35)
Diabetes (46)
Diagnostics (1110)
Diversity, equity & inclusion (41)
Drug pricing (43)
Earnings (7638)
Employer resources (124)
Events (12209)
Executive appointments (95)
FDA (2776)
Funding (94)
Gene therapy (80)
GLP-1 (319)
Government (1056)
Healthcare (3416)
Infectious disease (796)
Interviews (152)
IPO (1764)
Job creations (1750)
Job search strategy (740)
Layoffs (213)
Legal (1088)
Lung cancer (65)
Management (42)
Manufacturing (91)
Medical device (2151)
Medtech (2152)
Mergers & acquisitions (4052)
Metabolic disorders (183)
Neuroscience (433)
NextGen Class of 2024 (1649)
Non-profit (867)
Northern California (258)
Obesity (111)
Opinion (133)
People (10696)
Phase I (2866)
Phase II (4266)
Phase III (4603)
Pipeline (107)
Podcasts (87)
Policy (51)
Postmarket research (342)
Preclinical (1234)
Press Release (33)
Radiopharmaceuticals (68)
Rare diseases (90)
Real estate (2569)
Recruiting (52)
Regulatory (3267)
Reports (42)
Research institute (623)
Resumes & cover letters (164)
Southern California (182)
Startups (1092)
The Weekly (53)
United States (2173)
Vaccines (216)
Weight loss (119)
Date
Today (6)
Last 7 days (102)
Last 30 days (653)
Last 365 days (7005)
2024 (6427)
2023 (7092)
2022 (11235)
2021 (11731)
2020 (10036)
2019 (8576)
2018 (6288)
2017 (6277)
2016 (5972)
2015 (6751)
2014 (4389)
2013 (2714)
2012 (2730)
2011 (3079)
2010 (2395)
Location
Africa (347)
Asia (5635)
Australia (980)
California (519)
Canada (151)
China (62)
Europe (18089)
Florida (81)
Georgia (33)
Illinois (67)
Indiana (34)
Maryland (76)
Massachusetts (417)
Michigan (47)
Minnesota (38)
New Jersey (209)
New York (137)
North Carolina (119)
Northern California (258)
Pennsylvania (107)
South America (412)
Southern California (182)
Texas (73)
Washington State (39)
105,263 Results for "chiesi farmaceutici spa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
Gossamer Bio, Inc. and Chiesi Farmaceutici S.p.A announced that they have entered into a global collaboration and license agreement to develop and commercialize seralutinib.
May 6, 2024
·
9 min read
Deals
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
Chiesi Farmaceutici S.p.A. announced the completion of the acquisition of Amryt Pharma Plc, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing, and commercializing novel treatments for rare diseases.
April 12, 2023
·
3 min read
Bio NC
Chiesi to Present New Data Showcasing Depth of Respiratory Leadership at the American Thoracic Society 2024 International Conference
Chiesi USA, Inc. (key-A-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), today announced the presentation of eight abstracts from Chiesi’s global respiratory research portfolio at the American Thoracic Society (ATS) 2024 International Conference in San Diego from May 17-22, 2024.
May 16, 2024
·
6 min read
Deals
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Chiesi Farmaceutici S.p.A. and Amryt Pharma Plc announced that the companies have entered into a definitive agreement under which Chiesi will acquire Amryt.
January 8, 2023
·
12 min read
Business
Nemysis Limited Announces a Strategic Alliance With Bruno Farmaceutici S.p.A.
Nemysis is pleased to announce that it has entered into a Strategic Alliance Agreement with Bruno Farmaceutici S.p.A. for the mutual advancement of the portfolio and sales of each company.
November 8, 2023
·
2 min read
Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis
Chiesi Farmaceutici S.p.A and Haisco Pharmaceutical Group Co.Ltd announced the execution of a Licensing Agreement to develop, manufacture, and commercialise outside China and adjacent territories HSK31858, a novel, reversible dipeptidyl peptidase 1 inhibitor for respiratory diseases.
November 20, 2023
·
2 min read
Deals
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici.
March 22, 2023
·
6 min read
Genetown
Chiesi Global Rare Diseases Showcases Ongoing Commitment to Multiple Rare Diseases Communities at ENDO 2024 Meeting Debut
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, announced updates from their rare endocrine disease portfolio with two late-breaking poster presentations and one oral presentation during the Endocrine Society’s ENDO 2024 Meeting that was held June 1-4, 2024, in Boston, Massachusetts.
June 14, 2024
·
9 min read
Business
Chiesi USA Appoints Richard Smith as Vice President and Business Unit Leader, U.S. AIR
Chiesi USA, Inc. today announced it has appointed Richard Smith as vice president and business unit leader of U.S. AIR.
April 15, 2024
·
4 min read
Genetown
Chiesi Global Rare Diseases Makes Debut in the Endocrinology Landscape with Multiple Presentations at the Endocrine Society’s ENDO 2024 Meeting
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced that three abstracts have been accepted for presentation at the Endocrine Society’s ENDO 2024 Meeting to be held June 1-4, 2024, in Boston, Massachusetts.
May 22, 2024
·
5 min read
1 of 10,527
Next
